Nautilus Group (NLS) 23.64 $NLS Nautilus (NLS) Looks

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nautilus Group (NLS) 23.64 $NLS

Nautilus (NLS) Looks Good: Stock Adds 7.5% in Session
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 7:00AM CDT
Nautilus Inc. (NLS) was a big mover last session, as the company saw its shares rise over 7% on the day.
NSIT: 31.03 (+0.13), NLS: 23.64 (+0.50)

Mettler-Toledo International Set to Join the S&P 500; Monolithic Power Systems to Join S&P MidCap 400; WCI Communities and Nautilus to Join S&P SmallCap 600
PR Newswire - Thu Aug 25, 4:47PM CDT
S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices:
SPGI: 125.43 (+1.49), TYC: 45.59 (+0.58), APO: 18.90 (+0.14), MPWR: 77.37 (-0.29), OUTR: 51.79 (-0.03), NLS: 23.64 (+0.50), JCI: 45.45 (+0.41), WCIC: 18.80 (+0.01), MTD: 401.55 (-3.17)

Nautilus, Inc. Reports Strong Results for the Second Quarter 2016
BusinessWire - Mon Aug 01, 3:05PM CDT
--Operating Income Grew 67% to $6.6 Million and EPS from Continuing Operations Increased 71% to 12 cents
NLS: 23.64 (+0.50)

Retail Stocks' Q2 Earnings Slated on Aug 1: TXRH, HVT, NLS
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 6:38AM CDT
Let's take a look at a few Retail/Wholesale stocks that are queued up for second-quarter 2016 earnings releases on Aug 1.
HVT: 19.78 (+0.32), NLS: 23.64 (+0.50), TXRH: 44.42 (+0.15)

Nautilus, Inc. to Present at the 36th Annual Piper Jaffray Consumer Conference
BusinessWire - Wed Jun 08, 7:30AM CDT
June 8, 2016 - Nautilus, Inc. (NYSE: NLS) today announced that Sid Nayar, Chief Financial Officer, and William B. McMahon, Chief Operating Officer, will be presenting at the 36th Annual Piper Jaffray Consumer Conference, to be held June 14-15, 2016, at The Lotte New York Palace Hotel in New York, New York.
NLS: 23.64 (+0.50)

Research Shows Octane Fitness(R) Zero Runner(R) Delivers Equivalent Workouts to Treadmill
BusinessWire - Tue Jun 07, 8:30AM CDT
June 7, 2016 - A recent university study shows that the Zero Runner by Octane Fitness, a Nautilus(R), Inc. (NYSE:NLS) brand, elicits the same physiological response as treadmills during steady-state aerobic exercise. The data indicates that the Zero Runner offers a comparable workout as running on a treadmill, minus the repetitive impact to the body.
NLS: 23.64 (+0.50)

Will Nautilus (NLS) Continue to Surge Higher?
Zacks Equity Research - Zacks Investment Research - Wed May 25, 8:14AM CDT
As of late, it has definitely been a great time to be an investor in Nautilus Inc. (NLS).
NLS: 23.64 (+0.50)

Nautilus, Inc. to Present at the 17th Annual B. Riley & Co. Annual Investor Conference
BusinessWire - Thu May 19, 7:30AM CDT
May 19, 2016 - Nautilus, Inc. (NYSE: NLS) today announced that Bruce M. Cazenave, Chief Executive Officer; Sid Nayar, Chief Financial Officer; and William B. McMahon, Chief Operating Officer, will be presenting at the 17th Annual B. Riley & Co. Annual Investor Conference, to be held May 25-26, 2016, at The Loews Hollywood Hotel in Los Angeles, California.
NLS: 23.64 (+0.50)

Nautilus, Inc. Increases Share Repurchase Program to $25 Million
BusinessWire - Mon May 09, 3:10PM CDT
May 9, 2016 - Nautilus, Inc. (NYSE: NLS) today announced that its Board of Directors approved a $10 million share repurchase program, bringing the total authorization under its existing program to $25 million. The Company has completed approximately $11.6 million in share repurchases under its repurchase program first announced in November 2014, and may repurchase the balance of $3.4 million remaining under the original $15 million repurchase authorization through November 3, 2016. Shares may be repurchased under the $10 million expansion of the program from time to time over the next 24 months in open market transactions at prevailing prices, in privately negotiated transactions, or by other means in accordance with federal securities laws. The timing, number and value of shares repurchased under the program will depend on a number of factors, including the market price of Nautilus' common stock, general market and economic conditions, assessment of alternate uses of cash and applicable legal requirements.
NLS: 23.64 (+0.50)

Nautilus, Inc. to Announce First Quarter 2016 Results on Monday, May 9, 2016
BusinessWire - Mon Apr 25, 7:30AM CDT
April 25, 2016 - Nautilus, Inc. (NYSE: NLS), a leader in innovative fitness equipment, today announced that the Company will report its financial results for the first quarter ended March 31, 2016, after the market closes on May 9, 2016, followed by a management hosted conference call to discuss the Company's operating results.
NLS: 23.64 (+0.50)

Uptrend Call Working As Nautilus Stock Rises 14.1% (NLS)
Comtex SmarTrend(R) - Mon Feb 01, 11:45AM CST
SmarTrend identified an Uptrend for Nautilus (NYSE:NLS) on October 29th, 2015 at $17.01. In approximately 3 months, Nautilus has returned 14.08% as of today's recent price of $19.40.
NLS: 23.64 (+0.50)

Nautilus, Inc. Applies to Cease Reporting in Canada
BusinessWire - Fri Jan 22, 5:15PM CST
January 22, 2016 -- Nautilus, Inc. (NYSE: NLS) announced today that it has applied to securities regulatory authorities in Ontario, British Columbia and Nova Scotia for a decision that it is not a reporting issuer. If that decision is made, Nautilus will cease to be a reporting issuer in Canada and as such will not be required to file financial statements and other disclosure documents with Canadian regulatory authorities. Canadian securityholders will continue to receive all disclosure materials required under U.S. securities law or NYSE requirements to be delivered to U.S. resident securityholders. An order by the aforementioned securities regulatory authorities granting Nautilus' application will not affect the Company's NYSE listing or its reporting practices in the United States.
NLS: 23.64 (+0.50)

Shares of NLS Up 22.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jan 22, 12:45PM CST
SmarTrend identified an Uptrend for Nautilus (NYSE:NLS) on October 29th, 2015 at $17.01. In approximately 3 months, Nautilus has returned 22.82% as of today's recent price of $20.89.
NLS: 23.64 (+0.50)

Nautilus Has Returned 22.8% Since SmarTrend Recommendation (NLS)
Comtex SmarTrend(R) - Fri Jan 22, 11:50AM CST
SmarTrend identified an Uptrend for Nautilus (NYSE:NLS) on October 29th, 2015 at $17.01. In approximately 3 months, Nautilus has returned 22.82% as of today's recent price of $20.89.
NLS: 23.64 (+0.50)

Bull of the Day: Nautilus Inc. (NLS)
Brian Hamilton - ZACKS - Thu Jan 21, 8:01AM CST
Bull of the Day: Nautilus Inc. (NLS)
NLS: 23.64 (+0.50)

Nautilus, Inc. Launches Bowflex(R) and Schwinn(R) Products in Australia and New Zealand
BusinessWire - Wed Jan 20, 6:00PM CST
January 20, 2016 -- Nautilus, Inc. (NYSE: NLS), a leader in innovative fitness equipment, today announced availability of the Bowflex Max Trainer(R) and Schwinn(R) Airdyne(R) AD 8 Total Fitness Bike in Australia and New Zealand.
NLS: 23.64 (+0.50)

Nautilus, Inc. Launches Bowflex(R) Product in Switzerland
BusinessWire - Wed Jan 20, 4:25AM CST
January 20, 2016 -- Nautilus, Inc. (NYSE: NLS), a leader in innovative fitness equipment, today announced availability of the Bowflex Max Trainer in Switzerland.
NLS: 23.64 (+0.50)

Nautilus, Inc. Launches Bowflex(R) and Schwinn(R) Products in the UK
BusinessWire - Wed Jan 20, 4:25AM CST
January 20, 2016: Nautilus, Inc. (NYSE: NLS), a leader in innovative fitness equipment, today announced availability of the Bowflex Max Trainer(R) and Schwinn(R) Airdyne(R) AD 8 Total Fitness Bike in the UK.
NLS: 23.64 (+0.50)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 271

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 139

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 190

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading

Top 5 Most Recently Viewed Articles

IONQ Achieves Record Stock Levels Amid Strong Growth Indicators

Updated Category News Views 243

IONQ Stock Reaches New Heights Recently, IONQ has made headlines as its stock skyrocketed to an unprecedented level of $47.41, marking a significant achievement for the company. With a robust market capitalization of $10.2 billion, this remarkable performance is a testament to the company's impressive growth trajectory and the strong belief investors hold in its future....

Continue Reading
Model 1 Commercial Vehicles Expands Leadership Team for Growth

Updated Category News Views 285

Model 1 Commercial Vehicles Announces Leadership Changes Model 1 Commercial Vehicles is thrilled to unveil a set of key leadership appointments aimed at enhancing its strategic direction and ensuring the company's ongoing success. These changes reflect the impressive growth trajectory the company has experienced over the past few years. Tony Matijevich Takes the Helm as...

Continue Reading
Texas Instruments: Unusual Options Trends Uncovered

Updated Category News Views 195

Texas Instruments Options Insights Financial powerhouses have made a notable bullish move on Texas Instruments. Our analysis reveals intriguing trends within the options market for Texas Instruments (NASDAQ: TXN), showcasing an unusual number of trades that pinpoint shifting market sentiments. Trading Sentiment Overview Diving deeper into the data, it appears that 58% of...

Continue Reading
SMCP Unveils Latest Interim Financial Report for 2025

Updated Category News Views 177

SMCP Announces Availability of Its Interim Financial Report SMCP is excited to share that its interim financial report for the six-month period ending June 30, 2025, is now available for public access. This report has been officially filed with the relevant regulatory authorities. Details on the Financial Report This financial report outlines the company's performance...

Continue Reading
Kevin O'Leary Discusses Business Leaders' Support for Trump

Updated Category News Views 159

Understanding O'Leary's Perspective on Business Leadership Kevin O’Leary, a prominent entrepreneur and investor from Shark Tank, has provided insight into the evolving relationship between business leaders and President Trump. In recent discussions, O’Leary emphasized that the admiration many tech CEOs and corporate leaders have for Trump is not solely about his tax...

Continue Reading